Primary care clinicians are uniquely positioned to identify and respond to substance use disorders because they see patients across the lifespan and often manage comorbid medical and mental health conditions. Early detection reduces harms such as overdose, infectious complications, and disruptions to employment and family life. Dr. Nora Volkow National Institute on Drug Abuse emphasizes that substance use disorders are chronic brain diseases with medical, social, and behavioral dimensions, underlining the need for routine screening in medical settings.
Practical screening approach
Implement universal screening using brief, validated instruments at intake and periodically thereafter. Tools such as the Alcohol Use Disorders Identification Test and the Drug Abuse Screening Test streamline identification while minimizing clinic burden. Incorporate single-item screening questions for alcohol and drug use into electronic health records to prompt clinicians. Pair screening with the SBIRT approach for screening, brief intervention, and referral to treatment as recommended by the Substance Abuse and Mental Health Services Administration. Use motivational interviewing techniques developed by Dr. William R. Miller University of New Mexico to conduct brief interventions that respect patient autonomy and readiness to change. Ensure that assessments evaluate pattern of use, functional impairment, and risk of withdrawal or overdose, and document results to guide follow-up.
Cultural, environmental, and follow-up considerations
Effective screening requires attention to confidentiality and stigma reduction. Many patients fear legal, employment, or social consequences; creating a nonjudgmental environment and explaining confidentiality limits increases disclosure. Be aware of territorial and environmental factors such as limited treatment access in rural areas, exposure to fentanyl in certain regions, and cultural attitudes toward substances in Indigenous, immigrant, or marginalized communities. Social determinants like housing instability, trauma, and unemployment are common drivers of substance use and influence engagement with care.
Establish clear pathways for timely referral and ongoing management including medication-assisted treatment when indicated, harm-reduction services such as naloxone distribution, and integration with behavioral health. Track outcomes and coordinate with community resources to address the broader consequences of untreated substance use, including family disruption and chronic disease burden. Training primary care teams, leveraging validated tools, and building local referral networks convert screening into meaningful, evidence-based action that reduces harm and improves long-term outcomes.